The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

One-stage vs. chromogenic assays in haemophilia A

På svenska

Author

Summary, in English

Haemophilia A severity is closely correlated to the factor VIII (FVIII) activity, which can be measured in different ways. The original one-stage clotting assay is still the most widely used. The two-stage coagulation assay eliminated many of the drawbacks of the one-stage assay and was further developed into the chromogenic assay, a two-staged test with purified coagulation factors in the first stage, and a FXa-specific chromogenic substrate in the second stage. In many patients with mild or moderate haemophilia A, there is a discrepancy between the one-stage and the two-stage assays. If only the one-stage assay is used, some patients will have normal FVIII levels and not be diagnosed as having haemophilia or be considered to have a milder bleeding risk than is the case. Other patients who have normal FVIII activity will be diagnosed as haemophilia A. All haemophilia treatment centre laboratories should have access to both one-stage and chromogenic FVIII:C assays. Appropriate standards should be employed to enable accurate FVIII:C measurement. Different assays to measure inhibitor activity to infused FVIII have been developed since 1959. Inhibitor results based on the one-stage or chromogenic FVIII:C assays are well correlated, but the one-stage assay may be influenced by nonspecific inhibition.

Publishing year

2015

Language

English

Pages

38-44

Publication/Series

European Journal of Haematology

Volume

94

Issue

s 77

Document type

Journal article review

Publisher

Wiley-Blackwell

Topic

  • Hematology

Keywords

  • Antibodies/analysis
  • Biological Assay/instrumentation
  • Blood Coagulation Tests/instrumentation
  • Chromogenic Compounds/chemistry
  • Coenzymes/analysis
  • Factor IX/metabolism
  • Factor VIII/analysis
  • Factor X/metabolism
  • Hemophilia A/blood
  • Humans
  • Mutation
  • Protein Structure, Tertiary
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity

Status

Published

ISBN/ISSN/Other

  • ISSN: 1600-0609